[Remote] Associate Director, Global Health Economics and Outcomes Research at Acadia Pharmaceuticals

Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, PharmaceuticalsIndustries

Requirements

Expertise in real-world evidence (RWE) development and deployment to support global integrated evidence plans
Ability to provide strategic guidance on health economics and outcomes research (HEOR) for optimal patient access, pricing, and reimbursement
Experience working in a federated operating model across enterprise functions including Global Medical Affairs (GMA), Clinical Development & Biostatistics, Access and Commercial, Regional, and in-Country teams
Capability to develop and execute RWE projects and strategies, including dissemination of technical deliverables related to real-world data and evidence
Strong collaboration skills to foster innovation, optimal population health, and patient centricity
Adherence to applicable Madrigal policies and procedures
Alignment with a dynamic, inclusive, high-performing culture valuing scientific excellence, operational rigor, and collaboration

Responsibilities

Support strategic goals of GHEOR, GMA, and broader business to drive patient access with optimal pricing and reimbursement for Madrigal’s medicines, focusing on Rezdiffra
Provide strategic guidance and robust evidence development to demonstrate value of medicines for liver health, primarily through real-world data and evidence for Rezdiffra and the Madrigal portfolio
Develop and execute RWE projects and strategies against global integrated evidence plans
Disseminate technical deliverables related to real-world data and evidence
Execute functional objectives (approximately 60% of role)
Provide support for strategic direction and adapt priorities to achieve business objectives (approximately 40% of role)
Work closely with GMA, Clinical Development & Biostatistics, Access and Commercial, Regional, and in-Country teams
Report to the Director, GHEOR (RWE)

Skills

Health Economics

Outcomes Research

HEOR

Pharmacoeconomics

Real World Evidence

Biostatistics

Clinical Research

Regulatory Affairs

FDA Submissions

Phase 3 Trials

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free